Introduction:The incidence of dengue has increased throughout the 2000s with a consequent global increase in atypical clinical forms. Methods: This study reports a series of cases of neurological dengue out of 498 confirmed cases of laboratory dengue in Goiânia, Brazil. Cases were confirmed based on viral RNA detection via polymerase chain reaction or IgM antibody capture. Results: Neurological symptoms occurred in 5.6% of cases, including paresthesia (3.8%), encephalitis (2%), encephalopathy (1%), seizure (0.8%), meningoencephalitis (0.4%), and paresis (0.4%). DENV-3 was the predominant circulating serotype (93%).
Conclusions:We reported dengue cases with neurological manifestations in endemic area.Keywords: Dengue. Neurological. Encephalopathy.Dengue is an acute febrile infectious disease of viral etiology that can progress to severe disease and shock 1,2 . The incidence of dengue has increased throughout the 2000s with a consequent global increase in atypical clinical forms 3 . Several studies have described neurological symptoms among the unusual viral manifestations 4-7 .We previously reported clinical and laboratory findings related to dengue severity and outcome in adult patients recruited during the epidemic period of 2005 to 2006 in Central Brazil 8 . In the present study, we focused on neurological findings in this large cohort of patients with confirmed dengue infections.This study reports findings from a series of cases with neurological manifestations of dengue out of 498 confirmed cases of laboratory dengue in the City of Goiãnia in Midwestern region of Brazil, from January 2005 to July 2006. Patients were enrolled from the major referral center for dengue, the Hospital of Tropical Diseases, as well as from private hospitals and primary healthcare units. The follow-up duration for hospitalized patients was defined from the first medical visit to the discharge date. The follow up duration for outpatients was measured as the interval between the first and second blood collections during the convalescent phase (~15 days).We prospectively collected baseline demographic and clinical information from all patients using a standard study protocol. Data on age, sex, previous dengue episodes, and key clinical symptoms (hypotension, intense abdominal pain, and bleeding) were recorded. Clinical data and laboratory tests were recorded daily in patient files and reviewed by the clinical coordinator at the end of the follow-up. Dengue cases were confirmed by: a) isolation of dengue virus (DENV) 9 or detection of viral ribonucleic acid (RNA) by multiplex-or real-time polymerase chain reaction (qPCR) 10 ; or b) immunoglobulin M (IgM) antibody-capture enzyme-linked immunosorbent assay (MAC-ELISA) of the first or second paired blood samples 11 . Confirmatory tests were performed at the State Central Laboratory and the University of São Paulo.Patients with clinical symptoms compatible with a diagnosis of dengue and neurological manifestations were included in this study. Neurological manifestations were defin...